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Background: Diacerein and aceclofenac drug product combination is used for the pain management in
osteoarthritis. The main aspects of the present study is to develop stability indicating, sensitive reverse phase
high-performance liquid chromatographic method for the simultaneous determination of diacerein and ceclofenac
in tablet dosage form. Were, the chromatographic separation was achieved on Kromasil C-18, 150 × 4.6 mm, 3.5-μm
analytical column using mobile phase double distilled water (pH 2.7 with glacial acetic acid)-acetonitrile (45:55 v/v).
Detector was set at 256 nm.
Results: The described method shows excellent linearity over a range of 75–2.5 μg/mL for diacerein and 150–5 μg/mL
for aceclofenac. The correlation coefficient for diacerein is 0.9999 and for aceclofenac is 0.9997.
Conclusions: The proposed method was found to be suitable for simultaneous determination and stability study of
diacerein and aceclofenac in tablet dosage form.
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Diacerein is chemically 1,8-diacetoxy-3-carboxyanthra-
quinone and is also known as diacetylrhein. This drug is
used in the treatment of osteoarthritis. After absorption,
the drug is metabolized to its active metabolite rhein [1].
Diacerein and rhein are anthraquinone compounds that
ameliorate the course of osteoarthritis [2-4]. Aceclofenac
is chemically (2-[(2,6-dichlorophenyl)amino] phenyl acet-
oxyacetic acid) [5-7]. It has analgesic properties and a
good tolerability profile in a variety of painful conditions.
A combined fixed dose of 50 mg diacerein and 100 mg
aceclofenac is available commercially as tablets and are
widely used for the treatment of osteoarthritis. The two
main aspects of drug product analysis that play an im-
portant role in shelf life determinations are assay of ac-
tive drug and degradants generated during the stability
study. However, most of reference HPLC methods are
less sensitive and not stability indicating [8-12]. Com-
parison of the proposed HPLC method with the refer-
ence HPLC methods is shown in Table 1.* Correspondence: shaikh_kabeerahmed@rediffmail.com
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any medium, provided the original work is propeStability indicating RP-HPLC method for the simultan-
eous determination of aceclofenac and diacerein in tablet
dosage form is not available in any pharmacopeia. Hence,
it was felt essential to develop and validate a sensitive,
accurate and stability indicating RP-HPLC method for
the simultaneous determination of aceclofenac and dia-
cerein in tablet dosage form. The chemical structures of
diacerein and aceclofenac used in this work are shown in
Figure 1. Overlain UV spectra of diacerein and aceclofe-
nac are shown in Figure 2.Methods
Chemicals
Diacerein and aceclofenac working standards were obtained
from Sir Sayyed College Aurangabad, India. Glacial acetic
acid, HPLC grade acetonitrile, sodium hydroxide, hydro-
chloric acid and hydrogen peroxide were obtained from
Merck Ltd., Mumbai, India. The 0.45-μm nylon filter was
obtained from Advanced Micro Devices Pvt Ltd. (Ambala
Cantt, India). The combination product of diacerein and
aceclofenac label claim (diacerein 50 mg and aceclofenac
100 mg) branded tablets were purchased from the IndianOpen Access article distributed under the terms of the Creative Commons
licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
rly cited.
Table 1 Comparison of the proposed HPLC method with the reference HPLC methods
Reference Method Experimental details Linearity range
(μg mL−1)
LOQ Remarks
7 HPLC C-18 column with methanol-0.02% of
ortho phosphoric acid in a ratio of 70:30
as mobile phase and UV detection at 275 nm
17-100 NA Narrow linearity range
8 HPLC ODS C-18 column with methanol and water
(70:30 v/v) as mobile phase and UV detection
at 275 nm
2-50 30 ng mL−1 Not stability indicating,
narrow linearity range
9 HPLC C-18 column with acetonitrile: 50 mM NaH2 PO4
in a ratio of 65:35 v/v as mobile phase and UV
detection at 276 nm
1.8-4.2 NA Narrow linearity range,
sensitivity not established
10 HPLC C-18 column with acetonitrile-0.05 M disodium
hydrogen orthophosphate in a ratio of 65:35
as mobile phase and UV detection at 271 nm
4-20 0.9 μg mL−1 Not stability indicating, less
sensitive, narrow linearity range
11 HPLC C-18 column with 65:35 v/v 0.01 M ammonium
acetate buffer, pH 6.5-acetonitrile as mobile
phase and UV detection at 270 nm.
40-160 0.4 μg mL−1 Less sensitive, narrow
linearity range
This paper HPLC Kromasil C-18, 150 × 4.6 mm, 3.5-μm analytical
column using buffer (pH 2.7, acetonitrile; 45:55 v/v)
as mobile phase and UV detection at 256 nm
5-150 0.021 μg mL−1 Stability indicating, wide linearity
range, more sensitive
HPLC, high performance liquid chromatography; LOQ, Limit of quantification; ODS, Octadecylsilane; NA, not available.
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experiment.Equipment
The chromatographic system used was an Agilent-1100
series (Bangalore, India) comprised of degasser, quaternary
pump, auto injector, column compartment and photodiode
array detector. The system was controlled through Em-
power Software (Orlando, Florida).Chromatographic conditions
Kromasil C-18, 150×4.6 mm, 3.5-μm column was used.
The mobile phase consists of double distilled water (pH 2.7
with glacial acetic acid)-acetonitrile (45:55 v/v). Isocratic
elution was at a flow rate of 1 mL/min and column
temperature at 25°C. Detector wavelength was kept at
256 nm using a photodiode array detector.Figure 1 The chemical structures of diacerein and aceclofenac.Preparation of standard solution
The standard stock solution was prepared by dissolving
25 mg diacerein and 50 mg of aceclofenac. Working
standard with 10 mL of dimethyl acetamide and dilution
with the mobile phase up to 100 mL. Standard solution
containing 25 μg/mL of diacerein and 50 μg/mL of ace-
clofenac was prepared by transferring 5 mL of standard
stock solution to 50-mL volumetric flask and diluting
with the mobile phase.Sample preparation
The average fill weight of 20 capsules was determined.
Accurately weighed sample powder (100 mg of aceclofe-
nac and 50 mg of diacerein) was transferred into a
200-mL volumetric flask. Dimethyl acetamide (20 mL)
was added and sonicated for about 20 min to dissolve;
then, mobile phase was added to obtain a volume of
200 mL. The centrifuged solution was filtered through
Figure 2 Overlain UV spectra of diacerein and aceclofenac.
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tion was transferred into a 50-mL volumetric flask and
diluted to volume with mobile phase.System suitability studies
The resolution, number of theoretical plates and peak
asymmetry were calculated for the standard solutions and
are shown in Table 2. The values obtained demonstrated
the suitability of the system for the analysis of these drugs
in combination. The typical chromatogram of the standard
solution is shown in Figure 3.Forced degradation study of drug product
Transferred sample powder equivalent to 100 mg of ace-
clofenac and 50 mg of diacerein into a 200-mL volumet-
ric flask was added with 20 mL of dimethyl acetamide
and sonicated for about 20 min to dissolve and was trea-
ted with acid, alkali and peroxide as described in Table 3.
The stress studies were performed as per International
Conference on Harmonisation (ICH) recommendation.
Results of stressed studies are summarized in Table 3.
Figures 4, 5 and 6 show degradation products formed
during the degradation study.Results and discussion
Optimization of the chromatographic conditions
The main criteria of a successful HPLC method develop-
ment for determination of diacerein and aceclofenac in
tablet dosage form was the method should be able to de-
termine the assay of both drugs in single run. The method
should be robust, stability indicating, free of interferenceTable 2 System suitability studies
Serial number Parameter Diacerein Aceclofenac
1 Theoretical plates 9687 17795
2 Resolution 25.53 -
3 Asymmetry factor 1.2 1.2
4 %RSD (peak area) 0.10 0.10
RSD, relative standard deviation.from degradation products and useful for routine use in
the quality control laboratory.
Our objective of the chromatographic method develop-
ment was to achieve a peak tailing factor that is <2, run
time up to 10 min, along with a resolution that is >5
between diacerein and aceclofenac. In order to optimize
the LC separation of aceclofenac and diacerein, initially,
the retention behavior of both the components was studied
in the pH range of 2.5-6.8 using mobile phases of buffer
(pH 2.5-6.8) and acetonitrile, methanol as organic modifier.
To ensure the resolution between diacerein and aceclo-
fenac not to less than 5, the method was as fast as possible,
an isocratic run was optimized using the mobile phase
consisted of double distilled water (pH adjusted 2.7 with
glacial acetic acid)-acetonitrile (45:55 v/v), isocratic elution
at flow rate of 1 mL/min and column temperature at 25°C.
Detector wavelength was kept at 256 nm using a photo-
diode array detector. This was selected as an appropriate
chromatographic condition, which gave good resolution
and acceptable peak parameters for both diacerein and
aceclofenac. The analytes of this combination had ad-
equate retentions, peak shape, less tailing and more reso-
lution. The chromatographic analysis time was 10 min. In
optimized conditions, diacerein, aceclofenac and their
degradants were well separated.
Experimental
Method validation
As per ICH guidelines [13] the method validation para-
meters were checked for linearity, precision, accuracy,
limit of detection, limit of quantitation and robustness.
Specificity
Photodiode array detection was used as an evidence of the
specificity of the method. Complete separation of diacerein
and aceclofenac was noticed in the presence of tablet excipi-
ents. In addition, there was no interference at the retention
time of diacerein and aceclofenac in the chromatogram of
placebo solution. In peak purity analysis with photo diode
detector, purity angle was less than purity threshold for both
the analytes. This shows that the peak of analytes was pure,
Figure 3 A typical chromatogram of the tablet: diacerein and aceclofenac.
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peak of analytes.
Linearity
Linearity of the method was tested from 10% to 300% of
the targeted level of the assay concentration (diacerein
25 μg/mL, aceclofenac 50 μg/mL) for both analytes.
Linearity solutions were injected. The calibration graphs
were obtained by plotting the peak area ratio against the
concentration of the drugs. The equations of the calibra-
tion curves for diacerein and aceclofenac obtained were
y ¼ 11; 194xþ 2; 477 and y ¼ 11; 926x 2; 248, respect-
ively. In the simultaneous determination, the calibration







Acidic/1 N HCl/60°C/20 min 30.1 28.6
Alkaline/0.1 NaOH/60°C/5 min 14.7 13.5
Oxidative/3% H2O2/ambient/45 min 0.5 0.2
Figure 4 Chromatogram of the acid hydrolysis-degraded tablet soluticoncentrations with correlation coefficient of 0.9999 for
diacerein and 0.9997 for aceclofenac.
Precision
The repeatability of the analytical method was evaluated by
assaying six sample solutions of diacerein 25 μg/mL and
aceclofenac 50 μg/mL during the same day, under the same
experimental conditions. Intermediate precision was evalu-
ated by assaying solutions on different days. Peak areas were
determined and compared. Precision was expressed as
percentage relative standard deviation (RSD%< 2). From
the data obtained, the developed RP-HPLC method was
found to be precise, and results are reported in Table 4. The
results obtained by the proposed method for repeatability
were compared with those of the literature HPLC method
(7) and found that %difference between %mean assay (n=6)
is 0.2% as shown in Table 6.
Accuracy (recovery test)
Accuracy of the method was studied by recovery experi-
ments. The recovery experiments were performed byon.
Figure 5 Chromatogram of the base hydrolysis-degraded tablet solution.
Figure 6 Chromatogram of the peroxide-degraded tablet solution.
Table 4 Results from validation studies
Serial number Paramater Diacerein Aceclofenac
1 Linearity range (μg/mL) 75-2.5 150-5
2 Correlation coefficient 0.9999 0.9997
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cebo. The recovery was performed at three levels: 50%,
100% and 150% of the label claim of the tablet (100 mg of
aceclofenac and 50 mg of diacerein). Placebo equivalent to
one tablet was transferred into a 200-mL volumetric flask,
and the amounts of aceclofenac and diacerein at 50%, 100%
and 150% of the label claim of the tablet were added. Three
samples were prepared for each recovery level. The solu-
tions were then analyzed, and the percentage recoveries
were calculated. The recovery values for diacerein and
aceclofenac are shown in Table 4.3 LOD (μg/mL) 0.0033 0.007
4 LOQ (μg/mL) 0.01 0.021




6 Precision RSD (%, n= 6; RSD%< 2)
Repeatability day 1 0.26 0.52
Intermediate precision 0.35 0.64
LOD, Limit of detection ; LOQ, Limit of quantification; RSD, relative standard
deviation.LOD and LOQ
The LOD and LOQ for diacerein and aceclofenac was
determined at a signal-to-noise ratio of 3:1 and 10:1,
respectively, by injecting a series of dilute solutions with
known concentrations. The LOD and LOQ are as shown in
Table 4.
Robustness
The robustness of a method is the ability to remain un-
affected by small changes in parameters. To determinethe robustness of the method, experimental conditions
were purposely altered, and system suitability para-
meters were evaluated. The flow rate of the mobile
phase was 1.0 mL/min. To study the effect of flow rate







Asymmetry factor 1 Flow rate
0.8 mL/min 1.2 1.2
1.0 mL/min 1.1 1.1
1.0 mL/min 1.1 1.1












%RSD (peak area) 1 Flow rate
0.8 mL 0.31% 0.24%
1.0 mL 0.21% 0.19%
1.2 mL 0.35% 0.15%












RSD, relative standard deviation.
Table 6 Determination of aceclofenac in tablets and
















Mean 100.3 100.1 0.2
%RSD 0.20 0.26
95% confidence interval 100.1 and 100.5 99.9 and 100.3
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0.2 units from 1.0 mL/min to1.2 mL/min and 0.8 mL/
min. The effect of column temperature on system suit-
ability parameters was studied at 20°C and 30°C instead
of 25°C. The effect of pH variation of buffer on system
suitability parameters was studied at pH 2.5 and pH 2.9
instead of pH 2.7. The effect of organic variation (aceto-
nitrile) in mobile phase on system suitability parameters
was studied at 90% and 110% instead of 100%. Robust-
ness results are shown in Table 5.Conclusions
The developed simple LC method for assay determination
of diacerein and aceclofenac is linear, precise, accurate and
specific. The method was validated to the requirements of
ICH, and the results were satisfactory. The developed
stability-indicating analytical method can be used for the
routine analysis of production samples, where sample load
is higher and high throughput is essential for faster deliv-
ery of results. Overall, the method provides a high
throughput solution for determination of diacerein and
aceclofenac.
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